By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Relmada Therapeutics 

  New York    U.S.A.
Phone: n/a Fax: n/a


Company News
Relmada Therapeutics Doses First Cohort Of Subjects In Human Clinical Trial Of D-Methadone 12/22/2014 9:07:42 AM
Relmada Therapeutics Announces Results Of Annual Shareholders Meeting 12/19/2014 7:41:08 AM
Relmada Therapeutics Nominated For Buzz Of BIO Contest At The 2015 Biotechnology Industry Organization (BIO) CEO & Investor Conference 12/5/2014 12:43:15 PM
Relmada Therapeutics Receives Health Canada Clearance To Commence First Clinical Study Of D-Methadone 12/2/2014 10:11:37 AM
Relmada Therapeutics To Present At LD MICRO Conference 11/24/2014 12:47:21 PM
Relmada Therapeutics Appoints Michael Becker As Senior Vice President Of Finance And Corporate Development 11/4/2014 9:05:50 AM
Relmada Therapeutics Reinforces Balance Sheet With $15.2 Million From Exercise Of Warrants 10/16/2014 6:40:51 AM
Relmada Therapeutics Appoints Julie J. Chen As Director Of Finance and Operations 10/2/2014 9:15:13 AM
Relmada Therapeutics Appoints Christopher W. James As Senior Director Of Clinical Development 9/18/2014 9:00:07 AM
Relmada Therapeutics Enters Into Agreement With Memorial Sloan-Kettering Cancer Center To Better Clarify Unique Mechanism Of Action For LevoCap ER 9/16/2014 8:58:29 AM